<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/9139BA05-F922-4E40-9734-69922A4E351A"><gtr:id>9139BA05-F922-4E40-9734-69922A4E351A</gtr:id><gtr:name>BCH Charities</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/48990B2D-6D88-4205-B3F4-58863EA78D0D"><gtr:id>48990B2D-6D88-4205-B3F4-58863EA78D0D</gtr:id><gtr:name>National Institute of Health and Medical Research (INSERM)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/818CD6C9-61EE-41F2-9F37-0C7A8F43E25D"><gtr:id>818CD6C9-61EE-41F2-9F37-0C7A8F43E25D</gtr:id><gtr:name>University of Birmingham</gtr:name><gtr:address><gtr:line1>Edgbaston Park Road</gtr:line1><gtr:line2>Edgbaston</gtr:line2><gtr:postCode>B15 2TT</gtr:postCode><gtr:region>West Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/6BE14EEB-8C76-4661-A42D-5BBE8B8AC5ED"><gtr:id>6BE14EEB-8C76-4661-A42D-5BBE8B8AC5ED</gtr:id><gtr:name>Technical University Dresden</gtr:name><gtr:address><gtr:line1>TU Dresden</gtr:line1><gtr:postCode>D-01062</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Germany</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/102F2A51-71E4-4ECA-A245-9B9C4858D7E4"><gtr:id>102F2A51-71E4-4ECA-A245-9B9C4858D7E4</gtr:id><gtr:name>MRC Harwell</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/D5337A10-AC8A-402A-8164-C5F9CC6B0140"><gtr:id>D5337A10-AC8A-402A-8164-C5F9CC6B0140</gtr:id><gtr:name>Queen Mary, University of London</gtr:name><gtr:department>William Harvey Research Institute</gtr:department><gtr:address><gtr:line1>Mile End Road</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>E1 4NS</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D5337A10-AC8A-402A-8164-C5F9CC6B0140"><gtr:id>D5337A10-AC8A-402A-8164-C5F9CC6B0140</gtr:id><gtr:name>Queen Mary, University of London</gtr:name><gtr:address><gtr:line1>Mile End Road</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>E1 4NS</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/9139BA05-F922-4E40-9734-69922A4E351A"><gtr:id>9139BA05-F922-4E40-9734-69922A4E351A</gtr:id><gtr:name>BCH Charities</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/48990B2D-6D88-4205-B3F4-58863EA78D0D"><gtr:id>48990B2D-6D88-4205-B3F4-58863EA78D0D</gtr:id><gtr:name>National Institute of Health and Medical Research (INSERM)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/818CD6C9-61EE-41F2-9F37-0C7A8F43E25D"><gtr:id>818CD6C9-61EE-41F2-9F37-0C7A8F43E25D</gtr:id><gtr:name>University of Birmingham</gtr:name><gtr:address><gtr:line1>Edgbaston Park Road</gtr:line1><gtr:line2>Edgbaston</gtr:line2><gtr:postCode>B15 2TT</gtr:postCode><gtr:region>West Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/6BE14EEB-8C76-4661-A42D-5BBE8B8AC5ED"><gtr:id>6BE14EEB-8C76-4661-A42D-5BBE8B8AC5ED</gtr:id><gtr:name>Technical University Dresden</gtr:name><gtr:address><gtr:line1>TU Dresden</gtr:line1><gtr:postCode>D-01062</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Germany</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/102F2A51-71E4-4ECA-A245-9B9C4858D7E4"><gtr:id>102F2A51-71E4-4ECA-A245-9B9C4858D7E4</gtr:id><gtr:name>MRC Harwell</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/0969A8FC-FEF3-4121-91A1-6CC10265F111"><gtr:id>0969A8FC-FEF3-4121-91A1-6CC10265F111</gtr:id><gtr:firstName>Louise</gtr:firstName><gtr:otherNames>Amanda</gtr:otherNames><gtr:surname>Metherell</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=MR%2FK020455%2F1"><gtr:id>75AAEAB2-2627-4C0E-AC59-F7EA8A947DDF</gtr:id><gtr:title>Antioxidant defence in adrenocortical cells</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>MR/K020455/1</gtr:grantReference><gtr:abstractText>Oxidative stress (OS) is involved in many human disease states including neurodegenerative diseases, cancer, stroke, diabetes and heart disease. We study patients with a rare disease called Familial Glucocorticoid Deficiency (FGD) in which the body fails to produce a glucocorticoid called cortisol. Patients with this disease do not have a mechanism to cope with stress. If their body becomes stressed, for example by illness, their blood sugar levels drop, they become liable to infections and they may die if untreated. ACTH, acting through its receptor, is the hormone that is produced in response to stress and it causes the cells of the adrenal gland to produce cortisol. We have previously found defects in three genes in this pathway that cause FGD. More recently we have discovered that defects in four genes usually associated with a cells defence against oxidative stress, can also cause the disease. Exactly how OS prevents cortisol secretion is not fully understood and we believe that other genes may also be involved. This project aims to discover the mechanism by which OS affects the cells of the adrenal to prevent them making cortisol. We also hope to find other genes in this pathway by studying the genetic make-up of FGD patients. If we can discover how the OS causes its effect then this might give us clues to the mechanism in other diseases like those listed above and it may then be possible to design drugs to reduce it.</gtr:abstractText><gtr:technicalSummary>Decades of research support the idea that oxidative stress (OS) initiates and promotes cardiovascular, neurologic, and immune-related conditions. OS may arise from an imbalance between the production of reactive oxygen species (ROS) and the detoxification of these species by antioxidant defence systems such as the glutathione and thioredoxin systems. At present, relatively little is known about the contribution of individual enzymes to the redox metabolism in different cell types. We have discovered mutations in four antioxidant (AO) genes in patients with Familial Glucocorticoid Deficiency (FGD) a disease of adrenal resistance to ACTH and loss of cortisol secretion. This suggests that the adrenal cortex may be exquisitely sensitive to ROS and AO defence of primary importance to this cell type. Failure of AO defence leads to increased ROS, decreased glutathione ratios, steroidogenic acute regulatory protein reduction and hence reduced steroidogenesis. 
Our aims are;
A Delineation of a larger spectrum of anti-oxidant genes involved in the pathogenesis of FGD by whole exome sequencing of 100 affected individuals to identify novel mono- or (possibly) oligogenic variants. 
B Assessment of the effect of knockdown of antioxidant genes in human adrenocortical cell lines (H295R and HAC15) on; 
i) ROS levels, glutathione ratio, STAR mRNA and protein levels
ii) steroidogenic profiles 
iii) altered AO gene expression
C To attempt to rescue the phenotype in knockdown cell lines
i) by pharmacological intervention
ii) by overexpression of another antioxidant system
Understanding the mechanisms by which OS causes adrenal cell dysfunction could have a much wider indirect impact. Such knowledge may be instructive in the wide range of more prevalent human disorders associated with OS (listed above). Utilising knockdown adrenal cell lines as models for OS and AO treatment as proposed here could give us insights into more effective treatments for these conditions.</gtr:technicalSummary><gtr:potentialImpactText>Decades of research support the idea that oxidative stress (OS) initiates and promotes cardiovascular, neurologic, and immune-related conditions. OS may arise from an imbalance between the production of reactive oxygen species (ROS) and the detoxification of these species by antioxidant defence systems such as the glutathione and thioredoxin systems. At present, relatively little is known about the contribution of individual enzymes to the redox metabolism in different cell types. We have identified mutations in four different antioxidant genes in patients with Familial Glucocorticoid Deficiency (OMIM 202200) causing isolated adrenal dysfunction. Our data suggest that, in humans, the glutathione and thioredoxin systems are crucial for ROS detoxification in adrenal cells. There are many publications on antioxidant defence by these systems in tissues and organs especially liver, heart and pancreas, but most of these studies have been performed in mice and rats. There has been no study of this system in the human adrenal. Characterising the antioxidant genes that cause FGD may lead to a better understanding of the mechanisms by which OS causes cell dysfunction in the adrenal and could have a much wider indirect impact. Such knowledge may be instructive in the wide range of more prevalent human disorders associated with oxidative stress including neurodegenerative diseases, cancer, stroke, diabetes and cardiac dysfunction. Utilising knockdown adrenal cell lines as models for OS and antioxidant treatment as proposed here could give us insights into more effective treatments for these conditions.</gtr:potentialImpactText><gtr:fund><gtr:end>2016-03-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2013-04-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>392467</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>National Institute of Health and Medical Research (INSERM)</gtr:collaboratingOrganisation><gtr:country>France, French Republic</gtr:country><gtr:department>INSERM U870 (Metabolic regulation, Nutrition and Diabetes)</gtr:department><gtr:description>FGD consortium</gtr:description><gtr:id>4469115D-1C57-4A89-B9DC-1849BB6E1F15</gtr:id><gtr:impact>Outputs are many publications describing disease causing mutations in patients with familial glucocorticoid deficiency. This collaboration is not multi-disciplinary.</gtr:impact><gtr:outcomeId>GG5wTgngiTS-2</gtr:outcomeId><gtr:partnerContribution>Contribution of patient samplescontribution of patient samples</gtr:partnerContribution><gtr:piContribution>Discovery of novel genes responsible for cases of familial glucocorticoid deficiency</gtr:piContribution><gtr:sector>Public</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>MRC Harwell</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Roger Cox MRC Harwell</gtr:description><gtr:id>DCD7F855-4F2A-4492-B623-2AC5E4C0119F</gtr:id><gtr:impact>Nature Genetics paper</gtr:impact><gtr:outcomeId>DA4HU8MPKjS-1</gtr:outcomeId><gtr:partnerContribution>Supply of wild-type, mutant and BAC rescued NNT mice</gtr:partnerContribution><gtr:piContribution>Adrenal histology in NNT mutant mice</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Birmingham</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>NNt zebrafish</gtr:description><gtr:id>15CCA976-2442-488A-B4CA-CB23E4888910</gtr:id><gtr:impact>no outcomes yet</gtr:impact><gtr:outcomeId>54610f80ab5549.23319793-1</gtr:outcomeId><gtr:partnerContribution>intellectual exchange</gtr:partnerContribution><gtr:piContribution>intellectual exchange</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Technical University of Dresden</gtr:collaboratingOrganisation><gtr:country>Germany, Federal Republic of</gtr:country><gtr:department>Children's Hospital</gtr:department><gtr:description>FGD consortium</gtr:description><gtr:id>84C25C73-3587-4ED9-A569-F63A416656E0</gtr:id><gtr:impact>Outputs are many publications describing disease causing mutations in patients with familial glucocorticoid deficiency. This collaboration is not multi-disciplinary.</gtr:impact><gtr:outcomeId>GG5wTgngiTS-1</gtr:outcomeId><gtr:partnerContribution>Contribution of patient samplescontribution of patient samples</gtr:partnerContribution><gtr:piContribution>Discovery of novel genes responsible for cases of familial glucocorticoid deficiency</gtr:piContribution><gtr:sector>Hospitals</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>BCH Charities</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Birmingham Children's Hospital Research Foundation</gtr:department><gtr:description>NNT cancer</gtr:description><gtr:id>782C6941-605D-448D-B482-97B9363D96D9</gtr:id><gtr:impact>none so far</gtr:impact><gtr:outcomeId>54610c26acc879.86440072-1</gtr:outcomeId><gtr:partnerContribution>intellectual exchange</gtr:partnerContribution><gtr:piContribution>intellectual exchange</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>125000</gtr:amountPounds><gtr:country>Trinidad and Tobago, Republic of</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>PhD fellowship</gtr:description><gtr:end>2020-01-02</gtr:end><gtr:fundingOrg>Ministry of Health, Trinidad and Tobago</gtr:fundingOrg><gtr:id>D64F4A5B-108E-45E7-8AAA-FBD48CBCD324</gtr:id><gtr:outcomeId>58a85c8ebe1614.54918568</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2017-02-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>clinical practice</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>0BD0D4E2-0221-4B83-96B9-90DE64F9225E</gtr:id><gtr:outcomeId>02550DE012B</gtr:outcomeId><gtr:type>Influenced training of practitioners or researchers</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>H295R human adrenocortical cell line with stable knockdown of glutathione peroxidase 1 (GPX1) gene, achieved by lentiviral delivery of shRNA targeting the gene.C</gtr:description><gtr:id>F3BDC8FC-BE33-44CE-9A2C-B7128A3B4A75</gtr:id><gtr:impact>Creation of this cell line has allowed us to assess the effect of knockdown of GPX1.</gtr:impact><gtr:outcomeId>ZZH5AjXxaWh</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>H295RGPX1KD</gtr:title><gtr:type>Cell line</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>H295R human adrenocortical cell line with stable knockdown of nicotinamide nucleotide transhydrogenase (NNT) gene, achieved by lentiviral delivery of shRNA targeting the gene.</gtr:description><gtr:id>0CFEE129-D5BE-461A-B616-E273FC0C4AB6</gtr:id><gtr:impact>Creation of this cell line has allowed us to study the effect of knockdown of NNT</gtr:impact><gtr:outcomeId>mXuEMPZ4rkk</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>H295RNNTKD</gtr:title><gtr:type>Cell line</gtr:type><gtr:yearFirstProvided>2013</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>H295R cell line with stable shRNA knockdown of PRDX3</gtr:description><gtr:id>0E47B30E-FC00-4595-89C4-B89C7BE3ABBF</gtr:id><gtr:impact>PhD thesis</gtr:impact><gtr:outcomeId>YMe32o98oRk</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>H295RPRDX3</gtr:title><gtr:type>Cell line</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>H295R cell line with stable knockdown of GPX1 and PRDX3</gtr:description><gtr:id>872E1F6A-98CE-488B-81D8-20D9CC2CEB7F</gtr:id><gtr:impact>PhD thesis</gtr:impact><gtr:outcomeId>LRuwC5qpDSQ</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>H295RdoubleKO</gtr:title><gtr:type>Cell line</gtr:type></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>0E563C70-83A8-4C59-9A6E-F5FC99EADA55</gtr:id><gtr:title>eLS</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/70a128e7e59226a0bdc91ba2c85ca251"><gtr:id>70a128e7e59226a0bdc91ba2c85ca251</gtr:id><gtr:otherNames>Meimaridou E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2001-01-01</gtr:date><gtr:isbn>9780470016176</gtr:isbn><gtr:outcomeId>56cdd204d6ecb7.48729842</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>629B6891-8512-481B-8BCE-A230D33F9D63</gtr:id><gtr:title>Whole-Exome Sequencing in the Differential Diagnosis of Primary Adrenal Insufficiency in Children.</gtr:title><gtr:parentPublicationTitle>Frontiers in endocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/74e15fa55925f0d3873ae267e93060ef"><gtr:id>74e15fa55925f0d3873ae267e93060ef</gtr:id><gtr:otherNames>Chan LF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1664-2392</gtr:issn><gtr:outcomeId>56cdcf67ba1090.93310861</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BB1A6A96-A152-45DF-B6B6-EC641D52AEC3</gtr:id><gtr:title>Sphingosine-1-phosphate lyase mutations cause primary adrenal insufficiency and steroid-resistant nephrotic syndrome.</gtr:title><gtr:parentPublicationTitle>The Journal of clinical investigation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6d8bd4f9629df5ee96a207d66f8e3dae"><gtr:id>6d8bd4f9629df5ee96a207d66f8e3dae</gtr:id><gtr:otherNames>Prasad R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0021-9738</gtr:issn><gtr:outcomeId>58a85aa06d62e1.55031201</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>42FD59CC-80A8-4889-9A94-EBE9B9A7DD7F</gtr:id><gtr:title>Familial glucocorticoid deficiency: New genes and mechanisms.</gtr:title><gtr:parentPublicationTitle>Molecular and cellular endocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/70a128e7e59226a0bdc91ba2c85ca251"><gtr:id>70a128e7e59226a0bdc91ba2c85ca251</gtr:id><gtr:otherNames>Meimaridou E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0303-7207</gtr:issn><gtr:outcomeId>5461097a2f7ef0.99444677</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>14BFCEC7-9F2B-4AC6-B776-64F5F89C7F4D</gtr:id><gtr:title>Oxidative stress and adrenocortical insufficiency.</gtr:title><gtr:parentPublicationTitle>The Journal of endocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6d8bd4f9629df5ee96a207d66f8e3dae"><gtr:id>6d8bd4f9629df5ee96a207d66f8e3dae</gtr:id><gtr:otherNames>Prasad R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0022-0795</gtr:issn><gtr:outcomeId>doi_55f9869868dbb4b8</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B7A5AFA0-AAA9-4330-940B-8637110905C8</gtr:id><gtr:title>NNT pseudoexon activation as a novel mechanism for disease in two siblings with familial glucocorticoid deficiency.</gtr:title><gtr:parentPublicationTitle>The Journal of clinical endocrinology and metabolism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7697cc56ecb9d8711fe94a816573e18c"><gtr:id>7697cc56ecb9d8711fe94a816573e18c</gtr:id><gtr:otherNames>Novoselova TV</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0021-972X</gtr:issn><gtr:outcomeId>doi_55f9869868d2c1a2</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CB6C875D-4EE3-4385-BD5D-D2F56490C377</gtr:id><gtr:title>Familial glucocorticoid deficiency: a diagnostic challenge during acute illness.</gtr:title><gtr:parentPublicationTitle>European journal of pediatrics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f9cf0c2d8fc4ebe3b692524b53cbf85d"><gtr:id>f9cf0c2d8fc4ebe3b692524b53cbf85d</gtr:id><gtr:otherNames>Habeb AM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0340-6199</gtr:issn><gtr:outcomeId>pm_14360_20_23708259</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D1F56AB1-DE42-420D-8CAB-0253DE6DFC8E</gtr:id><gtr:title>Adrenocortical development, maintenance, and disease.</gtr:title><gtr:parentPublicationTitle>Current topics in developmental biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/36549f82d3bb7613308e15a8dc209b59"><gtr:id>36549f82d3bb7613308e15a8dc209b59</gtr:id><gtr:otherNames>Yates R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0070-2153</gtr:issn><gtr:outcomeId>5461097a5befc4.47063959</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>89354F2E-03C0-47BB-8459-3B7E8109F161</gtr:id><gtr:title>Primary Adrenocortical Insufficiency Case Series: Genetic Etiologies More Common than Expected.</gtr:title><gtr:parentPublicationTitle>Hormone research in paediatrics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/edc2fe7639ce8894900658947aee03f0"><gtr:id>edc2fe7639ce8894900658947aee03f0</gtr:id><gtr:otherNames>Tsai SL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1663-2818</gtr:issn><gtr:outcomeId>56cdcf6793da99.23250639</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4FB5F396-5879-4024-BE9D-561C4C6D75F9</gtr:id><gtr:title>Thioredoxin Reductase 2 (TXNRD2) mutation associated with familial glucocorticoid deficiency (FGD).</gtr:title><gtr:parentPublicationTitle>The Journal of clinical endocrinology and metabolism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6d8bd4f9629df5ee96a207d66f8e3dae"><gtr:id>6d8bd4f9629df5ee96a207d66f8e3dae</gtr:id><gtr:otherNames>Prasad R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0021-972X</gtr:issn><gtr:outcomeId>5461097aac4cd6.75055350</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F813EF40-3FE9-46AD-9F43-20DABDF5933E</gtr:id><gtr:title>ACTH resistance: genes and mechanisms.</gtr:title><gtr:parentPublicationTitle>Endocrine development</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/70a128e7e59226a0bdc91ba2c85ca251"><gtr:id>70a128e7e59226a0bdc91ba2c85ca251</gtr:id><gtr:otherNames>Meimaridou E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1421-7082</gtr:issn><gtr:outcomeId>pm_14360_20_23392095</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D4A47C35-61DA-46BB-AE94-399382E3A96A</gtr:id><gtr:title>Modeling Congenital Adrenal Hyperplasia and Testing Interventions for Adrenal Insufficiency Using Donor-Specific Reprogrammed Cells.</gtr:title><gtr:parentPublicationTitle>Cell reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a4dc6de0c8b03f25b94f80d597765ee0"><gtr:id>a4dc6de0c8b03f25b94f80d597765ee0</gtr:id><gtr:otherNames>Ruiz-Babot G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:outcomeId>5aa15b497e9275.40840235</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>81EE3579-93F7-459A-A779-2831FF842352</gtr:id><gtr:title>Deficiency of ALADIN impairs redox homeostasis in human adrenal cells and inhibits steroidogenesis.</gtr:title><gtr:parentPublicationTitle>Endocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6d8bd4f9629df5ee96a207d66f8e3dae"><gtr:id>6d8bd4f9629df5ee96a207d66f8e3dae</gtr:id><gtr:otherNames>Prasad R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0013-7227</gtr:issn><gtr:outcomeId>pm_14360_20_23825130</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3797260F-643A-4EB2-95D4-9D4E9BAD3F74</gtr:id><gtr:title>Three-Dimensional Model of Human Nicotinamide Nucleotide Transhydrogenase (NNT) and Sequence-Structure Analysis of its Disease-Causing Variations.</gtr:title><gtr:parentPublicationTitle>Human mutation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/efffd827f4cf03299dd1a9576ea0f846"><gtr:id>efffd827f4cf03299dd1a9576ea0f846</gtr:id><gtr:otherNames>Metherell LA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1059-7794</gtr:issn><gtr:outcomeId>58a85aa098dd71.47265056</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9A53E58C-0BC5-4257-B6E3-F012CD4FE2AC</gtr:id><gtr:title>NNT is a key regulator of adrenal redox homeostasis and steroidogenesis in male mice.</gtr:title><gtr:parentPublicationTitle>The Journal of endocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/70a128e7e59226a0bdc91ba2c85ca251"><gtr:id>70a128e7e59226a0bdc91ba2c85ca251</gtr:id><gtr:otherNames>Meimaridou E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>0022-0795</gtr:issn><gtr:outcomeId>5aa15b49bd7867.89524478</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MR/K020455/1</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>F3822669-BB5A-4BB4-BAE0-DCB9DE36E092</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Generic Health Relevance</gtr:text></gtr:healthCategory><gtr:healthCategory><gtr:id>160D22D0-5677-4513-A0AC-7F3526B7F336</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Metabolic and Endocrine</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>